Back to Search
Start Over
Fascinating Chemopreventive Story of Wogonin: A Chance to Hit on the Head in Cancer Treatment
- Source :
- Current Pharmaceutical Design. 27:467-478
- Publication Year :
- 2021
- Publisher :
- Bentham Science Publishers Ltd., 2021.
-
Abstract
- Cancer, global havoc, is a group of debilitating diseases that strikes family as well as society. Cancer cases are drastically increasing these days. Despite many therapies and surgical procedures available, cancer is still difficult to control due to limited effective therapies or targeted therapies. Natural products can produce lesser side effects to the normal cells, which are the major demerit of chemotherapies and radiation. Wogonin, a natural product extracted from the plant, Scutellaria baicalensis has been widely studied and found with a high caliber to tackle most of the cancers via several mechanisms that include intrinsic as well as extrinsic apoptosis signaling pathways, carcinogenesis diminution, telomerase activity inhibition, metastasis inhibition in the inflammatory microenvironment, anti-angiogenesis, cell growth inhibition and arrest of the cell cycle, increased generation of H2O2 and accumulation of Ca2+ and also as an adjuvant along with anticancer drugs. This article discusses the role of wogonin in various cancers, its synergism with various drugs, and the mechanism by which wogonin controls tumor growth.
- Subjects :
- Telomerase
Chemosensitizer
Apoptosis
medicine.disease_cause
01 natural sciences
Metastasis
03 medical and health sciences
chemistry.chemical_compound
Wogonin
Cell Line, Tumor
Neoplasms
Drug Discovery
medicine
Humans
030304 developmental biology
Pharmacology
0303 health sciences
biology
business.industry
Cancer
Hydrogen Peroxide
Cell cycle
medicine.disease
biology.organism_classification
0104 chemical sciences
010404 medicinal & biomolecular chemistry
chemistry
Flavanones
Cancer research
Scutellaria baicalensis
Carcinogenesis
business
Drugs, Chinese Herbal
Subjects
Details
- ISSN :
- 13816128
- Volume :
- 27
- Database :
- OpenAIRE
- Journal :
- Current Pharmaceutical Design
- Accession number :
- edsair.doi.dedup.....36d0b5c490cae40130f336a647b3f602